BA02 - Hypertensive Kidney Disease: Complete ICD-11 Coding Guide

1. Introduction

Hypertensive renal disease represents one of the most serious and frequent complications of uncontrolled arterial hypertension, constituting one of the leading causes of chronic kidney disease worldwide. This medical condition is characterized by progressive damage to the kidneys resulting from prolonged exposure to elevated blood pressure levels, affecting the structure and function of renal blood vessels and nephrons.

The clinical relevance of hypertensive renal disease transcends the individual scope, representing a significant challenge for health systems globally. Millions of people develop this condition annually, often silently, until renal function is substantially compromised. Disease progression can lead to end-stage renal failure, necessitating renal replacement therapies such as dialysis or transplantation, procedures that consume considerable resources from health systems.

Precise coding of hypertensive renal disease using ICD-11 code BA02 is fundamental for multiple purposes: it enables appropriate epidemiological tracking of the condition, facilitates appropriate allocation of health resources, enables robust clinical research, ensures correct reimbursement of medical procedures, and, crucially, ensures adequate continuity of patient care through accurate medical records. Correct differentiation between hypertensive renal disease and other forms of kidney disease is essential for establishing appropriate therapeutic strategies and realistic prognoses.

2. Correct ICD-11 Code

Code: BA02

Description: Hypertensive kidney disease

Parent category: null - Hypertensive diseases

Official definition: Hypertensive kidney disease is a medical condition that refers to kidney damage due to chronic hypertension.

This specific ICD-11 code was developed to precisely capture cases where arterial hypertension is identified as the primary cause of renal impairment. Code BA02 is situated within the broader category of hypertensive diseases, recognizing that the kidney can be a significant target organ of uncontrolled hypertension. The classification allows healthcare professionals to properly document the causal relationship between hypertension and renal dysfunction, differentiating this condition from other nephropathies that may coexist with hypertension without direct causal relationship. The correct use of this code requires clear documentation of the presence of chronic hypertension and evidence of renal impairment attributable to this hypertension, excluding other primary causes of kidney disease.

3. When to Use This Code

The BA02 code should be applied in specific clinical scenarios where there is clear evidence of renal damage secondary to chronic arterial hypertension. Below, we present detailed practical situations:

Scenario 1: Confirmed Hypertensive Nephrosclerosis Patient with a long-standing history of arterial hypertension (more than 10 years), inadequately controlled, who develops progressive elevation of serum creatinine, reduction in glomerular filtration rate, and mild to moderate proteinuria. Imaging studies show bilaterally reduced kidney size with thinned cortex. Renal biopsy, when performed, demonstrates characteristic vascular changes of hypertensive nephrosclerosis, including hyaline arteriolosclerosis and arterial intimal thickening. There is no evidence of other causes of renal disease such as diabetes, primary glomerulonephritis, or polycystic kidney disease.

Scenario 2: Chronic Renal Insufficiency in Long-Standing Hypertensive Patient Individual with established diagnosis of arterial hypertension for more than 15 years, with documented inadequate control at multiple visits, who presents with progressive deterioration of renal function over the years. The glomerular filtration rate has gradually decreased from normal values to less than 60 mL/min/1.73m², characterizing chronic kidney disease stage 3 or higher. Complementary tests exclude other causes of nephropathy, and the presentation pattern is consistent with hypertensive renal injury.

Scenario 3: Persistent Proteinuria in Hypertensive Context Hypertensive patient who develops persistent proteinuria (elevated urinary protein-to-creatinine ratio in multiple samples) without evidence of primary glomerulonephritis, diabetic disease, or other secondary causes. The presence of poorly controlled hypertension for a prolonged period, associated with the development of proteinuria and eventual decline in renal function, justifies coding as hypertensive renal disease.

Scenario 4: Progressive Microalbuminuria with Uncontrolled Hypertension Individual with essential hypertension who, despite initial treatment, maintains blood pressure above therapeutic targets and develops microalbuminuria that progresses to macroalbuminuria. Investigation excludes diabetes mellitus and other causes of proteinuria. The pattern suggests renal injury directly attributable to sustained hypertension.

Scenario 5: Renal Functional Decline Post-Hypertensive Crisis Patient who experienced recurrent episodes of severe hypertension or hypertensive crises, followed by sustained deterioration of renal function. After blood pressure stabilization, chronic renal impairment persists as documented by reduction in glomerular filtration and structural renal alterations attributable to previous hypertensive damage.

Scenario 6: Ultrasonographic Findings Compatible with Hypertensive Nephropathy Long-standing hypertensive patient with renal ultrasonography showing reduced kidney dimensions, increased cortical echogenicity and loss of corticomedullary differentiation, findings typical of chronic hypertensive nephropathy, accompanied by elevation of renal function markers and without other identifiable causes of renal disease.

4. When NOT to Use This Code

Specificity in coding requires clear understanding of situations where BA02 is not appropriate, avoiding errors that may compromise medical records and epidemiological analyses.

Hypertension Secondary to Primary Renal Disease When renal disease is the primary cause and hypertension is a consequence (renovascular hypertension, polycystic kidney disease, primary glomerulonephritis), code BA02 should not be used. In these cases, the primary renal condition should be coded appropriately, using specific codes for primary nephropathies. Secondary hypertension should be coded separately with appropriate code (1331849426).

Diabetic Nephropathy In diabetic patients who develop renal disease, even if they are also hypertensive, diabetic nephropathy is generally the primary cause of renal damage. The concomitant presence of hypertension does not justify the use of BA02, as the primary etiology is diabetes mellitus. The appropriate code for diabetic nephropathy should be used.

Primary Glomerulonephritis Conditions such as IgA nephropathy, membranoproliferative glomerulonephritis, or other primary glomerulonephritis have specific codes and should not be classified as hypertensive renal disease, even when hypertension coexists as a secondary complication.

Polycystic Kidney Disease This genetic condition has its own coding and should not be classified under BA02, even though it frequently presents with arterial hypertension.

Interstitial Nephritis or Chronic Pyelonephritis Chronic inflammatory or infectious renal diseases have distinct etiologies and specific codes, and should not be confused with hypertensive renal disease.

Recent Hypertension without Established Renal Damage Patients with recent diagnosis of hypertension, without evidence of renal impairment (normal renal function, absence of proteinuria, preserved renal structure), should not receive code BA02. Essential hypertension without renal complications should be coded as BA00.

5. Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

Confirmation of hypertensive renal disease diagnosis requires systematic evaluation and adequate documentation of multiple elements. First, the presence of chronic arterial hypertension must be established, ideally documented in multiple visits over months or years. The definition of chronic hypertension generally requires systolic blood pressure equal to or greater than 140 mmHg and/or diastolic pressure equal to or greater than 90 mmHg on multiple measurements.

The second essential component is documentation of renal impairment. This includes evaluation of estimated glomerular filtration rate, using validated equations based on serum creatinine, age, sex, and other factors. Reduction of glomerular filtration below 60 mL/min/1.73m² for a period exceeding three months characterizes chronic kidney disease. Additionally, the presence of proteinuria should be investigated through urinalysis, urine protein-to-creatinine ratio, or 24-hour urine collection.

Imaging studies, particularly renal ultrasound, provide valuable information about renal dimensions, cortical echogenicity, and presence of scars or structural alterations. Kidneys of reduced size with increased echogenicity suggest chronic disease.

Fundamentally, other causes of renal disease must be excluded through detailed clinical history, complete physical examination, and appropriate complementary investigations, including blood glucose, glycated hemoglobin, serologies when indicated, and possibly renal biopsy in selected cases.

Step 2: Verify Specifiers

Hypertensive renal disease presents a spectrum of severity that must be adequately documented. Classification of chronic kidney disease in stages (1 to 5) based on glomerular filtration rate provides important prognostic information and guides therapeutic decisions.

The duration of hypertension must be documented, as chronicity is an essential element to establish causal relationship with renal damage. Short-duration hypertension rarely causes significant renal disease.

Additional characteristics include the degree of proteinuria (microalbuminuria versus macroalbuminuria), presence of hematuria, urinary sediment alterations, and imaging findings. Documentation of blood pressure control over time, including usual pressure levels and response to antihypertensive treatment, provides relevant clinical context.

Step 3: Differentiate from Other Codes

BA00: Essential hypertension The fundamental difference is the absence of documented renal impairment. Patients with BA00 present with arterial hypertension without evidence of target organ damage, including kidneys. Normal renal function, absence of proteinuria, and preserved renal structure characterize BA00, while BA02 requires documentation of renal injury.

BA01: Hypertensive heart disease This code is used when hypertension causes primary cardiac impairment, such as left ventricular hypertrophy, heart failure, or coronary artery disease. Although patients may have both cardiac and renal impairment simultaneously, BA01 focuses specifically on cardiac complications, while BA02 focuses on renal ones. When both are present, multiple codes may be appropriate.

BA03: Hypertensive crisis Represents acute and severe elevation of blood pressure with or without acute target organ injury. It is an acute condition, unlike hypertensive renal disease which is chronic. A patient may have hypertensive crisis (BA03) superimposed on chronic hypertensive renal disease (BA02), but they are temporally distinct entities.

Step 4: Required Documentation

Adequate documentation to justify code BA02 must include:

Checklist of Mandatory Information:

• History of arterial hypertension with duration, usual pressure values, and previous treatments
• Serum creatinine values and estimated glomerular filtration rate on multiple occasions
• Results of urine tests documenting proteinuria or other abnormalities
• Reports of renal imaging studies (ultrasound, computed tomography, or magnetic resonance when performed)
• Documented exclusion of other causes of renal disease (diabetes, glomerulonephritis, obstruction, etc.)
• Antihypertensive medications used and response to treatment
• Relevant comorbidities and cardiovascular risk factors
• Specialist evaluations when performed (nephrologist, cardiologist)

The medical record must clearly narrate the temporal and causal relationship between hypertension and development of renal disease, demonstrating that renal impairment is a consequence of chronic hypertension and not of other conditions.

6. Complete Practical Example

Clinical Case

A 58-year-old male patient presents for routine consultation. Medical history reveals a diagnosis of arterial hypertension for 18 years, initially treated irregularly with inconsistent therapeutic adherence. Over the past 5 years, despite regular treatment with multiple antihypertensive agents, blood pressure remains frequently above 150/95 mmHg.

Approximately 3 years ago, routine examinations began showing progressive elevation of serum creatinine. The oldest available result from 4 years ago showed creatinine of 1.0 mg/dL (estimated glomerular filtration rate of 85 mL/min/1.73m²). Subsequent examinations showed progression: 2 years ago creatinine of 1.4 mg/dL (estimated GFR 58 mL/min/1.73m²), 1 year ago creatinine of 1.6 mg/dL (estimated GFR 48 mL/min/1.73m²), and currently creatinine of 1.8 mg/dL (estimated GFR 42 mL/min/1.73m²).

Current urinalysis shows proteinuria ++, without significant hematuria or leukocyturia. Urine protein-to-creatinine ratio: 0.8 g/g (moderate proteinuria). Recent renal ultrasound demonstrates kidneys with slightly reduced dimensions bilaterally (right 9.2 cm, left 9.0 cm), with increased cortical echogenicity and loss of corticomedullary differentiation, without evidence of obstruction or masses.

Complementary investigation: fasting blood glucose 98 mg/dL, glycated hemoglobin 5.6% (excluding diabetes), serologies for hepatitis B and C negative, normal serum complement, negative ANA. Fundoscopy shows grade II hypertensive changes (arteriolar narrowing and arteriovenous crossings).

Patient denies regular use of nonsteroidal anti-inflammatory drugs, no history of recurrent urinary tract infections, kidney stones, or familial polycystic kidney disease. Denies tobacco use, occasional social alcohol consumption.

Step-by-Step Coding

Criteria Analysis:

1. Documented chronic hypertension: Present for 18 years, with inadequate control documented in multiple consultations.

2. Progressive renal impairment: Documented decline in renal function over 4 years, with reduction in GFR from 85 to 42 mL/min/1.73m², characterizing chronic kidney disease stage 3B.

3. Significant proteinuria: Present at moderate levels, consistent with hypertensive renal injury.

4. Structural renal alterations: Ultrasound showing findings typical of hypertensive nephropathy (reduced kidneys, increased echogenicity).

5. Exclusion of other causes: Diabetes excluded, primary glomerulonephritis unlikely (negative serologies, absence of significant hematuria), no evidence of obstruction or polycystic disease.

6. Evidence of systemic vascular injury: Documented hypertensive retinopathy.

Code Selected: BA02 - Hypertensive kidney disease

Complete Justification:

The code BA02 is appropriate in this case because there is clear and documented evidence of renal damage secondary to long-standing arterial hypertension. The temporal relationship between poorly controlled hypertension for nearly two decades and the progressive development of chronic renal insufficiency in recent years establishes a causal relationship. The systematic exclusion of other causes of kidney disease (diabetes, glomerulonephritis, obstruction) strengthens the diagnosis of hypertensive kidney disease.

Clinical findings are consistent with hypertensive nephrosclerosis: progressive decline in renal function, non-nephrotic proteinuria, typical ultrasound alterations, and evidence of vascular injury in other organs (retinopathy). The pattern of presentation corresponds to what is expected in hypertensive kidney disease, differentiating it from other nephropathies.

Complementary Codes:

Depending on the coding system used and documentation needs, additional codes may be considered to specify the stage of chronic kidney disease, presence of proteinuria, and other relevant comorbidities, according to institutional protocols.

7. Related Codes and Differentiation

Within the Same Category

BA00: Essential Hypertension

When to use BA00: This code is appropriate for patients with primary arterial hypertension without evidence of target organ damage, including kidneys, heart, or brain. Patients with elevated blood pressure on multiple measurements but with normal renal function (GFR > 60 mL/min/1.73m²), absence of proteinuria, and preserved renal structure on imaging studies should be coded as BA00.

Main difference: The fundamental distinction between BA00 and BA02 is the presence or absence of documented renal damage. BA00 represents hypertension without renal complications, while BA02 indicates that hypertension has caused significant and measurable renal injury.

BA01: Hypertensive Heart Disease

When to use BA01: Use this code when arterial hypertension has caused primary cardiac compromise, manifested as left ventricular hypertrophy, hypertensive heart failure, hypertensive coronary artery disease, or other cardiac complications directly attributable to chronic hypertension.

Main difference: BA01 focuses on cardiovascular complications of hypertension, while BA02 focuses on renal complications. Patients may have both conditions simultaneously, in which case multiple codes may be necessary. Differentiation is based on the primary target organ affected as documented in the clinical evaluation.

BA03: Hypertensive Crisis

When to use BA03: This code is reserved for acute situations of severe blood pressure elevation (usually systolic > 180 mmHg and/or diastolic > 120 mmHg) with or without acute target organ injury. It represents hypertensive emergency or urgency requiring immediate intervention.

Main difference: BA03 is an acute and episodic condition, while BA02 represents chronic and progressive disease. A patient with chronic hypertensive renal disease (BA02) may present with an acute episode of hypertensive crisis (BA03), but these are temporally distinct entities. BA03 refers to the acute event, not to the chronic consequences of hypertension.

Differential Diagnoses

Diabetic Nephropathy Frequently confused with hypertensive renal disease, especially because diabetes and hypertension often coexist. Differentiation is based on the presence of diabetes mellitus as the primary cause of renal damage, typically with more significant proteinuria, concomitant diabetic retinopathy, and a specific pattern of progression. A history of diabetes preceding renal compromise suggests diabetic nephropathy as the primary diagnosis.

Chronic Glomerulonephritis Distinguished by clinical presentation frequently including significant hematuria, more pronounced proteinuria (often in the nephrotic range), altered serum complement in some cases, and when performed, renal biopsy showing specific patterns of glomerular injury. Hypertension may be a consequence of glomerulonephritis, not its cause.

Polycystic Kidney Disease Differentiated by frequent family history, presence of multiple renal cysts on imaging studies (easily identified on ultrasound), and characteristic pattern of progressive renal growth, in contrast to the reduction in size observed in hypertensive nephrosclerosis.

8. Differences with ICD-10

In the ICD-10 classification, hypertensive kidney disease was coded primarily as I12 (Hypertensive kidney disease), with subdivisions I12.0 (Hypertensive kidney disease with renal failure) and I12.9 (Hypertensive kidney disease without renal failure). The transition to ICD-11 with code BA02 brings important conceptual and practical changes.

ICD-11 simplifies coding by using a single code (BA02) for hypertensive kidney disease, eliminating subdivisions based on the presence or absence of renal failure. This approach recognizes that hypertensive renal damage exists on a continuous spectrum, and the binary distinction between "with" or "without" renal failure is artificial. In ICD-11, additional specifiers can be used to detail the stage of chronic kidney disease when necessary, offering greater flexibility.

The hierarchical structure of ICD-11 also provides better organization of hypertensive diseases, facilitating navigation and reducing ambiguities. Integration with electronic health systems is enhanced, allowing more precise coding and efficient data retrieval.

The practical impact of these changes includes the need to update health information systems, training of professionals for the new classification, and potential impact on longitudinal epidemiological studies that transition between classifications. The correspondence between I12 (ICD-10) and BA02 (ICD-11) should be documented in records to maintain historical continuity of data.

9. Frequently Asked Questions

How is hypertensive kidney disease diagnosed?

The diagnosis is established through a multifaceted approach that integrates detailed clinical history, physical examination, and complementary investigations. First, chronic arterial hypertension is documented through multiple blood pressure measurements over time. Simultaneously, renal function is evaluated through serum creatinine measurement and estimated glomerular filtration rate calculation. Urine tests identify proteinuria, an important marker of renal injury. Imaging studies, particularly renal ultrasonography, assess size, structure, and presence of characteristic alterations. Fundamentally, other causes of renal disease must be excluded through appropriate investigations including blood glucose, serologies, and in selected cases, renal biopsy. The integration of these elements allows establishing diagnosis with confidence.

Is treatment available in public health systems?

The treatment of hypertensive kidney disease primarily involves rigorous blood pressure control through lifestyle modifications and antihypertensive medications. Essential medications for blood pressure control, including angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, diuretics, calcium channel blockers, and beta-blockers, are generally available in public health systems globally, forming part of essential medication lists. Monitoring through regular medical consultations and basic laboratory tests is also typically accessible. In advanced stages, when renal replacement therapies such as dialysis are necessary, availability may vary between different health systems, but many countries offer access through specific public programs for chronic kidney disease.

How long does treatment last?

Hypertensive kidney disease is a chronic condition requiring continuous and indefinite treatment. Once established, renal injury is generally not reversible, although progression may be delayed or stabilized with appropriate treatment. Rigorous blood pressure control must be maintained permanently to prevent further deterioration of renal function and reduce cardiovascular risks. Patients require regular medical follow-up, generally every 3-6 months initially, with frequency adjustments based on blood pressure control and renal function stability. Periodic laboratory monitoring of renal function is essential to detect progression early. In advanced cases progressing to end-stage renal failure, dialytic treatment may be necessary indefinitely until eventual renal transplant.

Can this code be used in medical certificates?

Yes, code BA02 can and should be used in official medical documentation, including certificates, when appropriate. Precise coding in medical certificates facilitates communication between healthcare professionals, ensures continuity of care, and may be necessary for administrative processes such as work absences, disability benefit requests, or justifications for medical procedures. In certificates, in addition to the code, it is advisable to include textual description of the condition for clarity. The use of ICD-11 code in official documentation is becoming standard as health systems globally adopt the new classification, gradually replacing ICD-10 codes.

Can hypertensive kidney disease be reversed?

The reversibility of hypertensive kidney disease fundamentally depends on the stage at which it is diagnosed and the speed with which effective treatment is instituted. In very early phases, when renal damage is minimal and functional (without significant structural lesions), rigorous blood pressure control may result in improvement of renal function and reduction of proteinuria. However, once significant structural alterations such as nephrosclerosis, interstitial fibrosis, and loss of nephrons are established, the process is generally irreversible. The primary therapeutic objective then becomes delaying or stabilizing progression, preventing evolution to end-stage renal failure. This reality emphasizes the critical importance of early detection and aggressive treatment of hypertension before significant renal damage occurs.

What is the difference between hypertensive kidney disease and hypertension caused by kidney disease?

This is a crucial distinction frequently a source of confusion. In hypertensive kidney disease (BA02), hypertension is the primary cause and renal damage is the consequence. The patient develops hypertension first, and over years of elevated blood pressure, the kidneys are injured secondarily. In contrast, when primary kidney disease (such as glomerulonephritis, polycystic kidney disease, or diabetic nephropathy) causes secondary hypertension, the causal sequence is reversed: the kidney disease exists first and causes hypertension as a consequence. Differentiation is based on careful clinical history, temporal sequence of events, and investigations that identify or exclude primary causes of kidney disease. This distinction has important therapeutic and prognostic implications.

How frequently should renal function be monitored in hypertensive patients?

The frequency of monitoring depends on multiple factors including duration and severity of hypertension, presence of other risk factors, baseline renal function values, and blood pressure control. For hypertensive patients without evidence of kidney disease, annual evaluation of renal function (serum creatinine, estimated GFR) and urine examination are generally recommended. When hypertensive kidney disease is already established, more frequent monitoring is necessary: every 3-6 months for chronic kidney disease stages 3A and 3B, and more frequently (every 1-3 months) for more advanced stages (4 and 5). Adjustments in frequency are made based on renal function stability, therapeutic changes, and presence of complications. More intensive monitoring is also indicated after episodes of decompensation or when medications that may affect renal function are introduced.

What are the main risk factors for development of hypertensive kidney disease?

Various factors increase the risk of hypertensive patients developing kidney disease. The most important is inadequate blood pressure control over time; the higher the blood pressure and the more prolonged the exposure, the greater the risk of renal injury. Duration of hypertension is also critical, with risk increasing significantly after decades of disease. Other factors include: advanced age, ethnicity (some populations have increased risk), family history of kidney disease, concomitant diabetes mellitus, obesity, smoking, dyslipidemia, and preexisting cardiovascular disease. Presence of multiple cardiovascular risk factors amplifies the risk of renal complications. Early identification of these factors allows risk stratification and intensification of preventive therapy in higher-risk patients.

---

Conclusion

Precise coding of hypertensive kidney disease using ICD-11 code BA02 is a fundamental element in contemporary medical documentation, with implications that transcend administrative record-keeping. In-depth understanding of diagnostic criteria, appropriate clinical situations for code application, differentiation of similar conditions, and documentation requirements enables healthcare professionals to use this classification tool optimally. Early recognition of hypertensive kidney disease and its appropriate coding facilitate timely therapeutic interventions, potentially delaying progression to end-stage renal failure and improving clinical outcomes. As health systems globally adopt ICD-11, familiarity with codes such as BA02 becomes an essential competency for quality contemporary medical practice.

External References

This article was prepared based on reliable scientific sources:

1. 🌍 WHO ICD-11 - Hypertensive kidney disease
2. 🔬 PubMed Research on Hypertensive kidney disease
3. 🌍 WHO Health Topics
4. 📊 Clinical Evidence: Hypertensive kidney disease
5. 📋 Ministry of Health - Brazil
6. 📊 Cochrane Systematic Reviews

References verified on 2026-02-04